Acura Pharmaceuticals — A to Z Product Catalog
LTX-03 (LIMITx platform)
• Type: Immediate-release opioid tablet using LIMITx abuse-deterrent technology
• Indication: Intended to reduce opioid abuse potential
• Dose/Form: Investigational; not yet marketed
Nexafed® (pseudoephedrine)
• Generic: Pseudoephedrine
• Indication: Nasal decongestant (non-prescription cold, sinus, and allergy relief)
• Dose/Form: Oral tablets—standard pseudoephedrine dosing per OTC guidelines
Nexafed® Sinus Pressure + Pain
• Generic: Acetaminophen + Pseudoephedrine
• Indication: Relief of sinus pressure, congestion, and associated pain
• Dose/Form: Oral combination tablets—OTC, per standard dosing
Oxaydo® (oxycodone HCl)
• Generic: Oxycodone hydrochloride
• Indication: Management of acute and chronic moderate to severe pain (Schedule II opioid)
• Dose/Form: Oral tablets—abuse-deterrent formulation, dosing per prescribing information
VYCAVERT® (hydrocodone bitartrate + acetaminophen)
• Generic: Hydrocodone + Acetaminophen with abuse-deterrent features
• Indication: Intended for pain relief but designed to deter misuse
• Dose/Form: Investigational; abuse-deterrent version, not marketed
No comments:
Post a Comment